Patients Beyond weight loss: Exploring the impact of weight loss medi... It’s been less than two years since weight loss medications Wegovy and Mounjaro were approved in the UK to treat obesity.
Digital Highlighting the disruptors: Innovation for now and tomorrow... On Tuesday 19th March, pharmaphorum headed to King’s Place, London for the 10th annual WIRED Health conference - an event partnered with EY, Boston Scientific, and Lingo this year, which se
Events Partner Content Gut-Brain Axis 2018 On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year's ev
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.